Anne Cambon-Thomsen, MD, is Director of Research in CNRS (French national centre for scientific research) working in a research Unit on epidemiology and public health at Inserm (National Institute for Health and Medical Research), and University of Toulouse III Paul Sabatier, Faculty of Medicine Toulouse, France. Specialist in human immunogenetics, holding also a degree in health ethics, she leads an interdisciplinary research team on “Genomics, biotherapies and public health”, involving human and social sciences as well as health sciences and the “Genetics and Society” platform of the Toulouse-Midi-Pyrénées Genopole. She is involved in several EU projects in genomic sciences, public health genomics and biobanks, where she leads the work on ethical, legal and social issues. She sits in several scientific advisory boards of national and international projects and is the president of the national birth cohort ELFE (Etude longitudinale française des enfants) and a member of the board of the European and French Societies of Human Genetics and of the French “Rare diseases foundation”. Former member of the CCNE (French national advisory bioethics committee) and of the European Group on ethics of science and new technologies (EGE), past-Chair of the Life sciences operational ethics committee in CNRS, she is member of the ethics and policy committee of the International Cancer Genome Consortium (ICGC), of the deontology committee of the National Cancer Institute in France, of the ethics committee of the Toulouse White Biotechnology project (TWB) and of the steering committee for the national forum on synthetic biology. She worked in recent years on societal aspects of biobanks, biotherapies, genetic testing and biotechnologies. www.u1027.inserm.fr ; http://societal.genotoul.fr/